For informational purposes only — not investment advice

← Back to signals

GPN

LONGCONGRESS BUY

GLOBAL PMTS INC

Research: Finviz ↗·Perplexity ↗

🗄 Viewing archived Q1 2026 data — frozen, no longer refreshed.

Funds
3
Score
3.86
vs SPY
+19.1%
Stock return (since Q-end)
+38.8%
SPY return (since Q-end)
+19.7%
Current price
$93.05
Days to cover (short int.)
4.7d
as of 2026-06-30

News Summary

Positive

Global Payments completed the transformative $24B Worldpay acquisition and divested Issuer Solutions in January 2026, positioning itself as a pure-play merchant solutions leader. Q2 2026 results beat consensus with 12% adjusted EPS growth and strong free cash flow of $687M, though full-year guidance was modestly lowered due to Middle East conflict impacts on travel volumes. The company is executing well on integration with 30% improvement in merchant recruitment productivity and accelerating Genius platform adoption, while maintaining robust capital return commitments of >$2B for 2026.

Red flags

  • •Full-year 2026 guidance lowered in Q2 due to Middle East conflict reducing travel portfolio volumes through year-end
  • •Normalized adjusted net revenue growth guidance reduced to 4-5% (from ~5% prior), indicating moderation in underlying momentum
  • •GAAP diluted EPS of ($6.59) in Q1 2026 reflects significant non-recurring charges from acquisition and divestiture

Funds Buying (3)

FundManagerShares Held∆ SharesPosition Value% of FundQoQStatus
Glenview CapitalLarry Robbins6.4M+439K$428M11.6%+7%Existing
Point72Steve Cohen1.9M+1.9M$125M0.2%—NEW
Soros Fund ManagementSoros Family Office———3.0%+27%Existing

Shares Held and Position Value reflect total quarter-end holdings. ∆ Shares is the change from the prior quarter. % of Fund is the position's share of the fund's reported equity portfolio — it drives the size weighting in the conviction score.

Portfolio Context

Where GPN ranks in each buying fund's book, and the positions immediately around it. What a holding sits next to often says more about the thesis than the position size does.

Glenview Capital

position #2 of this fund's book

  1. 1CVS HEALTH CORP$589M
  2. 2GLOBAL PMTS INC$428M
  3. 3TENET HEALTHCARE CORP$288M
  4. 4AMAZON COM INC$221M
  5. 5TEVA PHARMACEUTICAL INDS LTD$201M

Values are quarter-end position sizes. Shown only for funds where GPN ranks inside their 40 largest equity positions — below that, neighbouring names carry no signal. Adjacency is an inference about a fund's reasoning, not a disclosure of it.

Beneficial Ownership (13D/13G)

FilerFormShares% of ClassFiledSrc
GTCR W Aggregator LPSC 13G43.3M15.4%2026-01-12↗

SC 13D = active intent to influence control (10-day filing deadline after crossing 5%). SC 13G = passive accumulation, no intent to influence control.

Congressional Trading

MemberChamberStateTypeAmount RangeTransaction DateFiledSrc
Alan Armstrongsenate—BUY$1,001 - $15,0002026-03-272026-07-21↗

Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures. Members often file weeks or months after trading, so trades are placed by transaction date: the badges above count trades dated since Jan 1, 2026.